OBJECTIVES: Fentanyl test strips (FTS) have the potential to moderate drug use behavior amidst an unregulated drug supply, yet are underutilized in medical settings. We aimed to describe emergency department (ED) FTS distribution across a large NYC health system and examine characteristics associated with clinicians’ ordering FTS compared with the current standard-of-care, take-home naloxone (THN), to identify opportunities to optimize FTS distribution.
METHODS: We conducted a retrospective review of THN and FTS provision across a large urban health system in its first year of FTS distribution. We evaluated the demographic and clinical characteristics of visits in which clinicians ordered FTS, compared with THN only.
RESULTS: From July 20, 2022 to July 20, 2023, 237 (of 423) clinicians ordered THN for 1279 unique individuals in 1376 eligible visits (436 with FTS, 940 without). In pairwise analysis, FTS receipt was associated with being male, younger, non-White, lacking commercial insurance; substance-related or overdose-related visit chief complaint or diagnosis, attending physician, and patient-directed discharge (P<0.05 for each). In multivariable regression, higher odds of FTS receipt were associated with male gender (OR=2.4; 95% CI=1.8–3.5), a substance-related chief complaint (OR=2.0; 95% CI=1.2–3.2) or visit diagnosis (OR=5.5; 95% CI=3.8–8.0), and overdose visit diagnosis (OR=1.7; 95% CI=1.1–2.8). Lower odds of FTS receipt were associated with older age (OR=0.98; 95% CI=0.97–0.99), noncommunity hospital sites (OR=0.71; 95% CI=0.60–0.83), and non-attending clinicians (OR=0.83; 95% CI=0.69–0.98).
CONCLUSIONS: Integrating FTS into an existing ED THN program was feasible without disrupting clinical workflow. ED encounters where FTS were dispensed differed significantly from THN-only, revealing opportunities to optimize FTS ordering.
Factors associated with emergency department distribution of fentanyl test strips
Journal of Addiction Medicine. doi: 10.1097/ADM.0000000000001651.